37.114.203 REPORTABLE DISEASES AND CONDITIONS (1) The following communicable diseases and conditions are reportable: (a) AIDS, as defined by the Centers for Disease Control and Prevention, and HIV infection, as determined by a positive result from a test approved by the Federal Food and Drug Administration for the detection of HIV, including, but not limited to, antibody, antigen, and all HIV nucleic acid tests; (b) Anaplasmosis; (c) Anthrax; (d) Arboviral Disease (California serogroup, Eastern equine encephalitis, Powassan, Saint Louis encephalitis, West Nile Virus, Western equine encephalitis); (e) Babesiosis; (f) Botulism (including infant botulism); (g) Brucellosis; (h) Campylobacter; (i) Chancroid; (j) Chlamydial trachomatis infection; (k) Cholera; (l) Coccidioidomycosis; (m) Colorado tick fever; (n) Cryptosporidiosis; (o) Cyclosporiasis; (p) Dengue virus infections; (q) Diphtheria; (r) Erlichiosis; (s) Escherichia coli, shiga toxin-producing (STEC); (t) Gastroenteritis outbreak; (u) Giardiasis; (v) Gonorrheal infection; (w) Granuloma inguinale; (x) Haemophilus influenzae invasive disease; (y) Hansen's disease; (z) Hantavirus pulmonary syndrome or infection; (aa) Hemolytic uremic syndrome, post diarrheal; (ab) Hepatitis A, acute; (ac) Hepatitis B, acute, chronic, perinatal; (ad) Hepatitis C, acute, infection, past or present; (ae) Influenza; (af) Lead poisoning (blood levels ≥ than 5 micrograms per deciliter for children 13 years of age or younger); (ag) Legionellosis; (ah) Listeriosis; (ai) Lyme disease; (aj) Lymphogranuloma venereum; (ak) Malaria; (al) Measles (rubeola); (am) Meningococcal disease (Neisseria meningitidis); (an) Mumps; (ao) Pertussis; (ap) Plague; (aq) Poliomyelitis, paralytic or non-paralytic; (ar) Psittacosis; (as) Q-fever; (at) Rabies in a human or animal; exposure to a human by a species susceptible to rabies infection; (au) Rickettsiosis (spotted fever); (av) Rubella (including congenital); (aw) Salmonellosis; (ax) Severe Acute Respiratory Syndrome-associated Coronavirus (SARS-CoV) disease; (ay) Shigellosis; (az) Smallpox; (ba) Streptococcus pneumoniae, invasive disease; (bb) Streptococcal toxic shock syndrome; (bc) Syphilis; (bd) Tetanus; (be) Tickborne relapsing fever; (bf) Toxic shock syndrome (nonstreptococcal); (bg) Transmissible spongiform encephalopathies; (bh) Trichinellosis (Trichinosis); (bi) Tuberculosis; (bj) Tularemia; (bk) Typhoid fever; (bl) Varicella; (bm) Vibriosis; (bn) Viral hemorrhagic fevers; (bo) Yellow fever; and (bp) Any unusual incident of unexplained illness or death in a human or animal with potential human health implications. History: 50-1-202, 50-17-103, 50-18-105, 50-18-106, MCA; IMP, 50-1-202, 50-2-118, 50-17-103, 50-18-102, 50-18-106, MCA; NEW, 1980 MAR p. 1579, Eff. 6/13/80; AMD, 1980 MAR p. 2870, Eff. 10/31/80; AMD, 1981 MAR p. 1289, Eff. 10/30/81; AMD, 1986 MAR p. 254, Eff. 2/28/86; AMD, 1987 MAR p. 2147, Eff. 11/28/87; AMD, 1994 MAR p. 1295, Eff. 5/13/94; AMD, 1995 MAR p. 1127, Eff. 6/30/95; AMD, 2000 MAR p. 2986, Eff. 9/22/00; TRANS, from DHES, 2002 MAR p. 913; AMD, 2006 MAR p. 2112, Eff. 9/8/06; AMD, 2013 MAR p. 967, Eff. 6/7/13. |